Big data-guided anti-aging drug discovery and its validation
Although aging is an inevitable process of human life, the rate of physiological deterioration is controllable. Physical exercise, heterochronic parabiosis, nutritional and pharmacological intervention have proven to be successful in slowing the rate of physiological deterioration. To lessen the massive socioeconomic burden of aging, it is imperative to develop safe and easily applicable anti-aging pharmaceutics. Notably, systematic profiling and analysis of previously generated NextGen sequencing data will enable the rapid discovery of new anti-aging pharmaceutics. Dr. Beck's research aims to identify and validate new and effective anti-aging pharmaceutics by taking advantage of big data analytics using a novel transcriptomic biomarker of aging.
